Global Veterinary In Vitro Fertilization (IVF) Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Global Veterinary in Vitro Fertilization (IVF) Market Analysis

The global veterinary in vitro fertilization (IVF) market is experiencing significant growth, driven by the rising demand for advanced reproductive technologies in animal breeding, particularly in livestock and companion animals. Increasing awareness about genetic advancements and the growing importance of improving animal health, fertility rates, and offspring quality are key factors boosting the market. Technological advancements in IVF techniques, such as embryo transfer, sperm preservation, and cryopreservation, are further contributing to the expansion of the market. The rising adoption of assisted reproductive technologies in the livestock industry to enhance productivity and ensure food security is creating new opportunities for market growth. The veterinary IVF market is also benefiting from favorable regulatory frameworks and government initiatives aimed at improving animal breeding practices and overall herd health.

Global Veterinary in Vitro Fertilization (IVF) Market Size

Global veterinary in vitro fertilization (IVF) market size was valued at USD 1.80 billion in 2024 and is projected to reach USD 2.76 billion by 2032, with a CAGR of 5.50% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Veterinary in vitro fertilization (IVF) Market Trends

“Rise in Focus on advanced reproductive technologies”

One key trend in the Global Veterinary In Vitro Fertilization (IVF) Market is the increasing adoption of advanced reproductive technologies in livestock breeding to improve productivity and genetic diversity. As global demand for high-quality meat and dairy products continues to rise, particularly in developing regions, farmers and breeders are increasingly turning to IVF and other assisted reproductive technologies to enhance herd quality, optimize reproductive efficiency, and increase yields. These technologies allow for better control over breeding processes, reducing the risks associated with traditional methods, and promoting the preservation of desirable genetic traits. This trend is especially prominent in regions such as North America and Europe, where advanced veterinary practices are more widely implemented, but is also gaining momentum in emerging markets.

In addition, innovations in IVF techniques, such as improved cryopreservation methods and more effective embryo transfer procedures, are making the process more accessible and successful. These advancements are reducing the overall cost and improving the success rates of veterinary IVF, encouraging wider adoption among breeders, especially in the livestock and equine industries. The use of cutting-edge technologies, such as genomic selection and embryo sexing, is also gaining traction, allowing breeders to select for specific traits and enhance genetic outcomes. This growing integration of technological innovations in the veterinary IVF market is expected to drive future growth and reshape breeding practices on a global scale.

Report Scope and Global Veterinary in vitro fertilization (IVF) Market Segmentation

Global Veterinary in Vitro Fertilization (IVF) Market Definition

Veterinary in vitro fertilization (IVF) is a reproductive technology used in animal husbandry and veterinary medicine that involves the collection of oocytes (eggs) from female animals, which are then fertilized with sperm in a controlled laboratory environment, outside the animal's body. This technique allows for the creation of embryos that can be subsequently transferred to recipient females, facilitating selective breeding, genetic improvement, and the preservation of endangered species.

Global Veterinary in Vitro Fertilization (IVF) Market Dynamics

Drivers  

• Rising Prevalence of Chronic Disease    

The growing demand for high-yield livestock, such as cattle (bovine) and sheep (ovine), significantly propels the global veterinary In Vitro Fertilization (IVF) market. As the world’s population expands, the necessity for sustainable food sources, particularly in livestock, becomes more pronounced. Traditional breeding methods often hinder genetic improvement and production efficiency. In contrast, IVF technology enhances breeding programs, allowing for considerable advancements in livestock genetics and productivity.  The adoption of advanced reproductive technologies, such as IVF, is especially beneficial in regions facing challenges related to livestock productivity, such as climate change and resource limitations. By optimizing breeding programs and boosting livestock production, IVF technology plays a crucial role in enhancing food security and promoting sustainable agricultural development.

For instance, in August 2023, according to an article published by Taylor & Francis Group, globally, there are approximately 19.6 billion chickens, 1.4 billion cattle, and 980 million pigs raised as livestock (2014). In Africa alone, livestock populations in 2018 included 2 billion poultry, 438 million goats, 384 million sheep, 356 million cattle, 40.5 million pigs, nearly 31 million camels, and 38 million equines (2020)              

• Rising Demand for Companion Animals             

The increasing rates of pet adoption and the growing demand for genetic screening in companion animals, including horses, dogs, and cats, are significant drivers of the global veterinary In Vitro Fertilization (IVF) market. As more people embrace pet ownership and view pets as integral family members, the focus on their health and well-being has intensified. This shift in attitude has led to a rising interest in advanced reproductive technologies such as IVF, which enhance breeding practices and support the health of companion animals. Pet owners are increasingly seeking genetic screening to ensure the health of their animals, identify hereditary conditions, and improve breeding outcomes. IVF plays a critical role in this process by facilitating the breeding of genetically superior animals while minimizing health risks associated with inbreeding. The ability to select for desirable traits and conduct genetic assessments empowers breeders to produce healthier, high-quality companion animals that meet the evolving demands of pet owners.

For instance, in September 2024, according to an article published by GlobalPETS, in South Korea, pets are increasingly regarded as family members, especially with the growing number of single-person households. In 2022, the average annual expenditure on pet services and products reached USD255 per person, the highest in four years, up from USD196 in 2019 and USD233 in 2021. Similar spending trends are observed in other East Asian countries such as China and Japan. This growing financial commitment to pet care underscores the rising demand for companion animals, which is expected to drive the global veterinary In Vitro Fertilization (IVF) market

Opportunities

• Increase In Research and Developmental Efforts

The increase in research and developmental efforts within the global veterinary In Vitro Fertilization (IVF) market represents a significant opportunity for various stakeholders, including veterinary clinics, biotechnology companies, and academic institutions. Enhanced R&D can lead to the development of innovative techniques, optimized protocols, and improved success rates for IVF in both companion animals and livestock. This not only meets the growing demand for advanced reproductive technologies but also positions veterinary IVF as a crucial component of animal breeding and health management practices. One of the key benefits of increased R&D efforts is the improvement of existing IVF techniques. Ongoing research can lead to the refinement of culture media, embryo selection processes, and cryopreservation methods. For instance, the development of more effective culture media can enhance embryo development and viability, thus improving overall success rates. As veterinary practitioners become more equipped with advanced techniques, they can offer better services to clients, boosting the market’s reputation and driving demand for such specialized services.

For instance, in July 2022, according to article published in The Science World, In Vitro Fertilization (IVF) technology has made significant advancements in the field of veterinary practice, offering new possibilities for animal breeding and reproductive management

• Advancements In Reproductive Technology

The advancement in reproductive technology, particularly in vitro fertilization (IVF) for animals, represents a significant growth prospect for the veterinary and livestock markets. As the agricultural industry, breeders, and even pet owners seek innovative ways to improve genetic lines, the use of sophisticated reproductive technologies, such as IVF, is gaining momentum. IVF allows for controlled breeding programs that can enhance desirable traits in livestock, such as disease resistance, productivity, and physical attributes, leading to more efficient and profitable farming practices. For pet owners, particularly those invested in purebred or rare animal breeds, IVF offers a controlled approach to ensuring the genetic quality and health of future generations, minimizing hereditary issues while fostering favorable characteristics. Additionally, the demand for preserving and enhancing endangered species through advanced reproductive technologies has opened up a specialized niche market. Innovations such as embryo freezing, gamete preservation, and genetic screening add another layer of value, as they allow for long-term storage and selection of superior genetics for future breeding purposes.

In April 2021, According to the article published by Hamilton Thorne, The Vibe anti-vibration platform, combined with Hamilton Thorne's precision instruments, represents a significant technological advancement in In Vitro Fertilization (IVF) for animals. In IVF procedures, even the slightest vibrations can negatively affect embryo quality and development, making a vibration-free environment essential for optimal outcomes. The Vibe platform is designed to minimize these disruptions by providing a stable, vibration-free surface for sensitive IVF equipment

Restraints/Challenges

• Risk Of Disease Transmission During IVF Procedures    

The success of veterinary IVF depends heavily on maintaining strict hygiene and sterilization protocols throughout the process. However, if proper precautions are not followed, there is a significant risk of contamination that can lead to disease outbreaks. During IVF procedures, several biological materials, such as sperm, oocytes, and embryos, are handled, often requiring multiple stages of transfer between lab environments and animals. Shared use of equipment such as catheters, incubators, and transfer tools can further heighten the risk of microbial contamination if not adequately sterilized between uses.

The risk of disease transmission acts as a barrier to the adoption of IVF technologies in veterinary settings. Veterinary clinics, breeders, and livestock producers may hesitate to invest in IVF solutions without confidence in robust safety measures. Frequent disease outbreaks could erode trust in IVF services and impose additional costs on veterinary professionals and breeders in the form of quarantine, medical treatments, or culling of infected animals.

For instance, in September 2022, according to an article published by International Veterinary Information Service, Feline Immunodeficiency Virus (FIV) is present in the semen of both chronically and newly infected cats, with the virus detectable even before the infected cat develops antibodies. Transmission of FIV from male to female has been documented through artificial insemination using fresh semen via laparoscopy  

• Lack Of Awareness in Underdeveloped Markets 

In many underdeveloped markets, the adoption of veterinary In Vitro Fertilization (IVF) technologies faces significant challenges due to a lack of awareness. This limitation is primarily rooted in inadequate infrastructure and insufficient education about the benefits of IVF in animal breeding and health management. Farmers and breeders in these regions may not be familiar with the advantages that IVF can offer, such as enhanced genetic diversity, improved reproductive outcomes, and the potential for disease management.

Moreover, the scarcity of veterinary professionals trained in advanced reproductive technologies contributes to this knowledge gap. Without access to education and resources, livestock producers may remain reliant on traditional breeding methods, which could hinder the growth of the IVF market. This lack of awareness not only restricts the potential benefits of IVF technologies but also perpetuates low investment levels in veterinary services.

For instance, in 2022, according to an article published by AiGGPA, infertility is a significant issue among cattle and buffalo in Madhya Pradesh, driven by livestock owners' ignorance and a lack of awareness, as well as inadequate treatment facilities in remote areas. These factors further hinder breed improvement programs, complicating efforts to address infertility in these animals. This situation underscores the "lack of awareness in underdeveloped markets" and highlights how insufficient knowledge and limited access to veterinary resources are substantial challenges for the global veterinary In Vitro Fertilization (IVF) market

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Veterinary in Vitro Fertilization (IVF) Market Scope

The market is segmented on the basis of products & services, animal type, technique, distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product & Services

• IVF and Embryo Culture Instruments
  • Microscopes
  • Co2 Incubators
  • Embryo Transfer Catheters
  • Laser Systems
  • Others
• Laboratory Equipment
  • Centrifuges
  • Refrigerators and Freezers
  • Microfuge Tubes and Plates
  • Others
• Cryosystems
• Monitoring Devices
  • Analyzers
  • pH Monitors
  • Others
• Imaging Systems
• Ovum Pick Up System
• Ovum Aspiration Pumps
• Cabinets
• Others
• Equipment
  • Benchtop
  • Standalone
• Reagents & kits
  • Media
    • Embryo culture media
    • Bovine media
    • Serum free culture media
    • Cryopreservation media
    • Equine media
  • Embryo assay
  • Kits
    • Devitrification kit
    • Verification cooling kit
    • Verification warming kit
    • Others
• Services
  • Oocyte retrieval and collection
  • Embryo culture and development
  • Cryopreservation
  • Genetic screening and selection
• Others

Animal Type

• Livestock Animal
  • Cattles
  • Sheep
  • Goat
  • Others
• Companion Animals
  • Horses
  • Dogs
  • Cats
  • Others
• Companion Animals
  • Equipment
  • Reagent
• Services

Technique

• Artificial Insemination
• Embryo Transfer
• Ovum Pickup
• In Vitro Maturation

Distribution Channel

• Direct Tenders
• Retail Sales
• Online Sales
• Others

End User

• Veterinary Fertility Clinics
• Veterinary Hospitals
• Surgical Centers
• Research Laboratories
• Cryobanks
• Others

Global Veterinary in vitro fertilization (IVF) Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, products & services, animal type, technique, distribution channel, and end user as referenced above.

The countries covered in the market are U.S., Canada, and Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Poland, Belgium, Austria, Netherlands, Switzerland, Hungary, Ireland, Lithuania, Norway, and Rest of Europe, China, Japan, India, Australia, South Korea, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Singapore, and Rest of Asia-Pacific, Brazil, Argentina, Peru and Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, and rest of Middle East and Africa.

North America is expected to dominate the market due to the region's well-established livestock industry, high adoption of advanced reproductive technologies, availability of skilled veterinary professionals, and strong support from government and private initiatives aimed at improving animal productivity and genetic quality.

Asia-Pacific is expected to be the fastest growing due to its expanding healthcare infrastructure, rising demand for companion animals, and increase in veterinary clinics offering IVF services.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Global Veterinary in vitro fertilization (IVF) Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Global Veterinary in vitro fertilization (IVF) Market Leaders Operating in the Market Are:

• Hamilton Thorne, Inc. (U.S.)
• Esco Medical (Singapore)
• Zoetis Services LLC (U.S.)
• Imy Technologies (U.S.)
• Minitube (Germany)
• Agetech Inc (U.S.)
• Orgensen Laboratories (U.S.)
• Bovine Elite LLC (U.S.)
• Kruuse (Denmark)
• Equine Fertility Centre (UK)
• Veterinary Group (U.S.)
• Stateline Veterinary Service (U.S.)
• Trans Ova Genetics (U.S.)
• Tri-Mitsu Pharmaceuticals (Japan)

Latest Developments in Global Veterinary in vitro fertilization (IVF) Market

• In September 2024, Zoetis and Danone announced a strategic partnership to enhance sustainability in dairy farming through genetics. By combining their expertise, they aimed to improve animal health, reduce environmental impact, and create resilient dairy herds, aligning with growing consumer demand for sustainable dairy products
• In October 2024, Esco Medical launched the MIRI Laminar Flow (MLF) Cabinet, designed for IVF clinics and laboratories. This innovative cabinet utilized vertical airflow and advanced filtration to ensure optimal sample protection, safety, and efficiency in laboratory environments
• In September 2024, IMV Technologies Group acquired UD-Vet B.V. UD-Vet are a leading provider of Veterinary practice equipment and other veterinary imaging modalities, based in Utrecht, Netherlands and Brussels, Belgium with a reach throughout the Benelux region
• In October 2023, Hamilton Thorne Ltd. has acquired Gynetics Medical Products N.V., enhancing its consumables portfolio in the European IVF market. This strategic acquisition increases recurring revenue opportunities and expands product offerings, reinforcing Hamilton Thorne’s commitment to high-quality assisted reproductive technologies
• In September 2022, Zoetis announced the completion of its acquisition of Jurox, enhancing its product range and global presence. This acquisition strengthened Zoetis' anesthetic portfolio with Alfaxan and provided valuable insights into the Australian animal health market

SKU-24594